Net Medical Xpress Solutions, Inc. (NMXS)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.07 Million USD | -18.15% |
| 2022 | 1.31 Million USD | 40.41% |
| 2021 | 938 Thousand USD | 144.91% |
| 2020 | 383 Thousand USD | -16.92% |
| 2019 | 461 Thousand USD | 38.44% |
| 2018 | 333 Thousand USD | -4.86% |
| 2017 | 350 Thousand USD | -25.05% |
| 2016 | 467 Thousand USD | -23.44% |
| 2015 | 610 Thousand USD | -34.2% |
| 2014 | 927 Thousand USD | 12.36% |
| 2013 | 825 Thousand USD | 6.31% |
| 2012 | 776 Thousand USD | 10.54% |
| 2011 | 702 Thousand USD | 1.15% |
| 2010 | 694 Thousand USD | -7.84% |
| 2009 | 753 Thousand USD | 37.66% |
| 2008 | 547 Thousand USD | 367.52% |
| 2007 | 117 Thousand USD | -67.68% |
| 2006 | 362 Thousand USD | -64.58% |
| 2005 | 1.02 Million USD | -2.76% |
| 2004 | 1.05 Million USD | 12.65% |
| 2003 | 933 Thousand USD | 1.41% |
| 2002 | 920 Thousand USD | -36.16% |
| 2001 | 1.44 Million USD | 331.44% |
| 2000 | 334 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.05 Million USD | -2.32% |
| 2023 Q2 | 1.14 Million USD | -6.78% |
| 2023 Q3 | 1.06 Million USD | -7.01% |
| 2023 Q1 | 1.22 Million USD | -6.99% |
| 2023 FY | 1.07 Million USD | -18.15% |
| 2023 Q4 | 1.07 Million USD | 1.51% |
| 2022 Q3 | 1.35 Million USD | 5.11% |
| 2022 Q4 | 1.31 Million USD | -3.02% |
| 2022 Q1 | 1.13 Million USD | 20.47% |
| 2022 Q2 | 1.29 Million USD | 14.34% |
| 2022 FY | 1.31 Million USD | 40.41% |
| 2021 FY | 938 Thousand USD | 144.91% |
| 2021 Q2 | 454 Thousand USD | -6.39% |
| 2021 Q3 | 983 Thousand USD | 116.52% |
| 2021 Q4 | 938 Thousand USD | -4.58% |
| 2021 Q1 | 485 Thousand USD | 0.0% |
| 2020 FY | 383 Thousand USD | -16.92% |
| 2019 FY | 461 Thousand USD | 38.44% |
| 2018 FY | 333 Thousand USD | -4.86% |
| 2018 Q1 | 332 Thousand USD | 0.0% |
| 2018 Q2 | 407 Thousand USD | 22.59% |
| 2017 Q3 | 541 Thousand USD | -5.09% |
| 2017 Q1 | 523 Thousand USD | 11.99% |
| 2017 Q2 | 570 Thousand USD | 8.99% |
| 2017 FY | 350 Thousand USD | -25.05% |
| 2016 Q3 | 564 Thousand USD | -21.88% |
| 2016 Q1 | 613 Thousand USD | 0.49% |
| 2016 Q4 | 467 Thousand USD | -17.2% |
| 2016 FY | 467 Thousand USD | -23.44% |
| 2016 Q2 | 722 Thousand USD | 17.78% |
| 2015 Q2 | 911 Thousand USD | 8.97% |
| 2015 Q3 | 726 Thousand USD | -20.31% |
| 2015 Q4 | 610 Thousand USD | -15.98% |
| 2015 Q1 | 836 Thousand USD | -9.82% |
| 2015 FY | 610 Thousand USD | -34.2% |
| 2014 Q3 | 1.16 Million USD | 18.03% |
| 2014 Q2 | 987 Thousand USD | 15.98% |
| 2014 Q1 | 851 Thousand USD | 3.15% |
| 2014 Q4 | 927 Thousand USD | -20.43% |
| 2014 FY | 927 Thousand USD | 12.36% |
| 2013 Q4 | 825 Thousand USD | -6.78% |
| 2013 FY | 825 Thousand USD | 6.31% |
| 2013 Q2 | 877 Thousand USD | 2.45% |
| 2013 Q3 | 885 Thousand USD | 0.91% |
| 2013 Q1 | 856 Thousand USD | 10.31% |
| 2012 Q2 | 827 Thousand USD | 15.83% |
| 2012 Q3 | 859 Thousand USD | 3.87% |
| 2012 FY | 776 Thousand USD | 10.54% |
| 2012 Q4 | 776 Thousand USD | -9.66% |
| 2012 Q1 | 714 Thousand USD | 1.71% |
| 2011 Q3 | 672 Thousand USD | -6.54% |
| 2011 Q1 | 768 Thousand USD | 10.66% |
| 2011 Q4 | 702 Thousand USD | 4.46% |
| 2011 FY | 702 Thousand USD | 1.15% |
| 2011 Q2 | 719 Thousand USD | -6.38% |
| 2010 Q2 | 649 Thousand USD | -14.61% |
| 2010 Q3 | 779 Thousand USD | 20.03% |
| 2010 Q4 | 694 Thousand USD | -10.91% |
| 2010 FY | 694 Thousand USD | -7.84% |
| 2010 Q1 | 760 Thousand USD | 0.93% |
| 2009 Q2 | 690 Thousand USD | 9.35% |
| 2009 FY | 753 Thousand USD | 37.66% |
| 2009 Q1 | 631 Thousand USD | 15.36% |
| 2009 Q4 | 753 Thousand USD | -6.58% |
| 2009 Q3 | 806 Thousand USD | 16.81% |
| 2008 Q4 | 547 Thousand USD | 35.73% |
| 2008 FY | 547 Thousand USD | 367.52% |
| 2008 Q1 | 177 Thousand USD | 51.28% |
| 2008 Q2 | 200 Thousand USD | 12.99% |
| 2008 Q3 | 403 Thousand USD | 101.5% |
| 2007 Q3 | 208 Thousand USD | -8.77% |
| 2007 Q1 | 384 Thousand USD | 6.08% |
| 2007 FY | 117 Thousand USD | -67.68% |
| 2007 Q2 | 228 Thousand USD | -40.63% |
| 2007 Q4 | 117 Thousand USD | -43.75% |
| 2006 Q3 | 707 Thousand USD | -5.61% |
| 2006 FY | 362 Thousand USD | -64.58% |
| 2006 Q4 | 362 Thousand USD | -48.8% |
| 2006 Q1 | 842 Thousand USD | -17.61% |
| 2006 Q2 | 749 Thousand USD | -11.05% |
| 2005 Q1 | 1.06 Million USD | 1.52% |
| 2005 Q2 | 989 Thousand USD | -7.31% |
| 2005 FY | 1.02 Million USD | -2.76% |
| 2005 Q4 | 1.02 Million USD | -3.04% |
| 2005 Q3 | 1.05 Million USD | 6.57% |
| 2004 FY | 1.05 Million USD | 12.65% |
| 2004 Q4 | 1.05 Million USD | 23.65% |
| 2004 Q3 | 850 Thousand USD | 3.53% |
| 2004 Q2 | 821 Thousand USD | -0.12% |
| 2004 Q1 | 822 Thousand USD | -11.9% |
| 2003 Q4 | 933 Thousand USD | -1.06% |
| 2003 FY | 933 Thousand USD | 1.41% |
| 2003 Q1 | 1.12 Million USD | 22.39% |
| 2003 Q3 | 943 Thousand USD | -8.98% |
| 2003 Q2 | 1.03 Million USD | -7.99% |
| 2002 FY | 920 Thousand USD | -36.16% |
| 2002 Q1 | 1 Million USD | -30.12% |
| 2002 Q2 | 898 Thousand USD | -10.82% |
| 2002 Q4 | 920 Thousand USD | 0.22% |
| 2002 Q3 | 918 Thousand USD | 2.23% |
| 2001 Q3 | 923 Thousand USD | 18.33% |
| 2001 Q4 | 1.44 Million USD | 56.12% |
| 2001 FY | 1.44 Million USD | 331.44% |
| 2001 Q2 | 780 Thousand USD | 22.83% |
| 2001 Q1 | 635 Thousand USD | 0.0% |
| 2000 FY | 334 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Achiko AG | 6.49 Million USD | 83.414% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | 8.37 Million USD | 87.124% |
| Cannabis Sativa, Inc. | 1.26 Million USD | 14.659% |
| CompuMed, Inc. | 1.34 Million USD | 19.867% |
| CompuGroup Medical SE & Co. KGaA | 1.45 Billion USD | 99.926% |
| Cogstate Limited | 16.91 Million USD | 93.627% |
| CareView Communications, Inc. | 40.52 Million USD | 97.34% |
| Craneware plc | 215.06 Million USD | 99.499% |
| Caduceus Software Systems Corp. | 5.57 Million USD | 80.663% |
| Certive Solutions Inc. | 10.95 Million USD | 90.161% |
| Drug Free Solution, Inc. | 333.29 Thousand USD | -223.433% |
| DATATRAK International, Inc. | 6.18 Million USD | 82.557% |
| Strainsforpains, Inc. | 2.61 Million USD | 58.709% |
| Healixa Inc. | 10.57 Million USD | 89.805% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | 138.29 Thousand USD | -679.521% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | 1.02 Million USD | -5.426% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | 5068.58 USD | -21168.284% |
| iCoreConnect Inc. | 11.24 Million USD | 90.411% |
| IQ-AI Limited | 796.65 Thousand USD | -35.315% |
| Cannabiz Mobile, Inc. | 559.05 Thousand USD | -92.826% |
| Mednow Inc. | 9.46 Million USD | 88.615% |
| Galileo Life Sciences, Inc. | 725.46 Thousand USD | -48.594% |
| MediXall Group, Inc. | 4.53 Million USD | 76.21% |
| Mitesco, Inc. | 14.13 Million USD | 92.373% |
| MobileSmith, Inc. | 6.15 Million USD | 82.485% |
| NantHealth, Inc. | 384.94 Million USD | 99.72% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | 11.33 Million USD | 90.487% |
| Patient Access Solutions, Inc. | 2.44 Million USD | 55.891% |
| Pharma-Bio Serv, Inc. | 3.77 Million USD | 71.446% |
| PPJ Healthcare Enterprises, Inc. | 7.03 Million USD | 84.686% |
| Medical Cannabis Payment Solutions, Inc. | 2.36 Million USD | 54.434% |
| Renalytix Plc | 15.82 Million USD | 93.188% |
| Revium Recovery Inc. | 144 Thousand USD | -648.611% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | 3.06 Million USD | 64.802% |
| Vaso Corporation | 48.91 Million USD | 97.796% |
| Vynleads, Inc. | 805.33 Thousand USD | -33.858% |